Zydus Healthcare buys 2 ANDAs from Teva
The estimated market size of the two ANDAs put together is nearly $200 million
Zydus Healthcare, a subsidiary of Cadila…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Latest Updates » Page 309
Browsing Category
Latest Updates
Study observes potential breakthrough in treatment of HIV
The study addresses the persistence of latent HIV reservoirs in patients who are on antiretroviral therapy
A study conducted by…
Nacimbio signs MoU with Cipla
Launches complex programme for antiretroviral drugs production
National Immunobiological Company (State Corporation Rostech)…
IIPA seeks to eliminate misconceptions around ePharmacy model
Aims a level playing field to drive innovation in this sector
US FDA strengthens existing warning on canagliflozin, dapagliflozin
Drug labels of both type 2 diabetes drugs to now include revised warnings on acute kidney injury and recommendations to minimise…
‘Pharmalytics is an end-to-end analytics platform providing localised data of the demand and…
CareOnGo, a mobile chain of co-branded pharmacy stores, recently launched a pharmalytics platform, Aditya Kandoi, Co founder at…
Jardiance (empagliflozin) reduces risk of progressive kidney disease in adults with type 2 diabetes…
Jardiance (empagliflozin) is the only SGLT2 inhibitor to demonstrate the potential to improve kidney outcomes on top of standard…
Mike Easterbrook joins Ideal Cures as Chief Technical Officer
In his new role, he will interact with customers' senior management and provide technical information, training and support
Low dose of stem cells might provide relief from arthritis of the knee
The study aimed to evaluate the safety and effectiveness of different doses of a type of stem cell called adipose-derived stromal…
FDA approves vaccine to prevent cholera for travelers
Vaxchora, the only FDA-approved vaccine for the prevention of cholere, is a live, weakened vaccine that is taken as a single, oral…